Seamless Phase II/III Combination Study Through Response Adaptive Randomization-Reference-Cited by-同舟云学术

Seamless Phase II/III Combination Study Through Response Adaptive Randomization

Published:2007-11-08 Issue:6 Volume:17 Page:1177-1187
ISSN:1054-3406
Container-title:Journal of Biopharmaceutical Statistics
language:en
Short-container-title:Journal of Biopharmaceutical Statistics

Author:

Wang Lin¹,Cui Lu²

Affiliation:

1. a Biostatistics and Programming, Sanofi Aventis , Bridgewater, New Jersey, USA

2. b Global Biostatistics, Eisai Medical Research , Ridgefield Park, New Jersey, USA

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,Statistics and Probability

Link

https://www.tandfonline.com/doi/pdf/10.1080/10543400701645322

Reference28 articles.

1. Combining different phases in the development of medical treatments within a single trial

2. Increasing the sample size when the unblinded interim result is promising

3. Adaptive Design Methods in Clinical Trials

4. A comparison of the randomized play-the-winner rule and the triangular test for clinical trials with binary responses

5. Cui , L. Hung , H. Wang , S. ( 1997 ). Impact of changing sample size in a group sequential clinical trial . ASA Proceedings of the Biopharmaceutical Section , pp. 52 – 57 .

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Use of Seamless Study Designs in Oncology Clinical Development– A Survey Conducted by IDSWG Oncology Sub-team;Therapeutic Innovation & Regulatory Science;2024-06-22

2. Seamless Clinical Trials with Doubly Adaptive Biased Coin Designs;The New England Journal of Statistics in Data Science;2023

3. A practical response adaptive block randomization (RABR) design with analytic type I error protection;Statistics in Medicine;2021-06-10

4. A Seamless Adaptive 2-in-1 Design Expanding a Phase 2 Trial for Treatment or Dose Selection Into a Phase 3 Trial;Statistics in Biopharmaceutical Research;2021-05-04

5. An adaptive seamless Phase 2-3 design with multiple endpoints;Statistical Methods in Medical Research;2021-02-15